Company page

Upstream Bio, Inc.

Upstream Bio, Inc. (ticker: UPB) is a public company based in the United States with a market capitalization of approximately $340 million. The company focuses on developing innovative therapies in the biopharmaceutical sector. Investors can find information about its operations and performance on its public company page.